Purchases and Sales Made in Q2 2024 in Bio Line Rx Ltd. (BLRX)
This table provides information about the institutional ownership of Bio Line Rx Ltd. (BLRX) during Q2 2024. The information is specifically focused on institutions that hold shares of BioLineRx Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Alyeska Investment Group, L.P.
Chicago, IL |
BUY
|
- |
1.95MNew |
$1.09M - $1.68M
|
1.95M
$938K
|
|
|
Aug 15, 2024
Q2 2024
|
Cvi Holdings, LLC
Wilmington, DE |
BUY
|
- |
816KNew |
$457K - $701K
|
816K
$392K
|
|
|
Aug 08, 2024
Q2 2024
|
Envestnet Asset Management Inc
|
BUY
|
- |
159K+ 293.04% |
$89.3K - $137K
|
214K
$103K
|
|
|
Aug 13, 2024
Q2 2024
|
Atria Investments LLC
Charlotte, NC |
BUY
|
- |
105KNew |
$58.7K - $90.1K
|
105K
$50.3K
|
|
|
Aug 22, 2024
Q2 2024
|
Pvg Asset Management Corp
Golden, CO |
BUY
|
- |
61.7K+ 99.84% |
$34.6K - $53.1K
|
124K
$59.3K
|
|
|
Aug 22, 2024
Q2 2024
|
Cetera Investment Advisers
Schaumburg, IL |
BUY
|
- |
53.6K+ 297.49% |
$30K - $46.1K
|
71.7K
$34.4K
|
|
|
Jul 30, 2024
Q2 2024
|
Orin Green Financial, LLC
|
BUY
|
- |
43KNew |
$24.1K - $37K
|
43K
$20.6K
|
|
|
Aug 14, 2024
Q2 2024
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
29K+ 167.77% |
$16.2K - $24.9K
|
46.2K
$22.2K
|
|
|
Aug 13, 2024
Q2 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
24K+ 74.92% |
$13.4K - $20.6K
|
56K
$26.9K
|
|
|
Jul 18, 2024
Q2 2024
|
Gradient Investments LLC
|
BUY
|
- |
21K+ 233.33% |
$11.8K - $18.1K
|
30K
$14.4K
|
|
|
Jul 12, 2024
Q2 2024
|
Weaver Consulting Group
|
BUY
|
- |
16.9KNew |
$9.48K - $14.6K
|
16.9K
$8.12K
|
|
|
Aug 01, 2024
Q2 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
7.41K+ 40.42% |
$4.15K - $6.37K
|
25.7K
$12.4K
|
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1.5KNew |
$841 - $1.29K
|
1.5K
$720
|
|
|
Aug 13, 2024
Q2 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
200+ 16.58% |
$112 - $172
|
1.41K
$675
|
|
|
Jul 19, 2024
Q2 2024
|
Values First Advisors, Inc.
|
BUY
|
- |
126+ 0.06% |
$70.6 - $108
|
204K
$97.8K
|
|
|
Aug 15, 2024
Q2 2024
|
Creative Planning
Overland Park, KS |
BUY
|
- |
99+ 0.76% |
$55.4 - $85.1
|
13.1K
$6.28K
|
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2024
Q2 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-800- 5.78% |
$448 - $688
|
13K
$6.26K
|
|
|
Jul 02, 2024
Q2 2024
|
Gamma Investing LLC
Foster City, CA |
SELL
|
- |
-3.77K- 94.54% |
$2.11K - $3.24K
|
218
$105
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-11.1K- 88.22% |
$6.21K - $9.54K
|
1.48K
$710
|
|
|
Aug 07, 2024
Q2 2024
|
Lpl Financial LLC
Fort Mill, SC |
SELL
|
- |
-18.3K- 18.26% |
$10.3K - $15.8K
|
82K
$39.4K
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-86.7K- 42.33% |
$48.6K - $74.6K
|
118K
$56.7K
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-223K- 76.51% |
$125K - $192K
|
68.4K
$32.8K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-223K- 76.51% |
$125K - $192K
|
68.4K
$32.8K
|